Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

This grant supports investigator-initiated single-site clinical trials, including efficacy, comparative effectiveness, pragmatic, and dissemination/implementation science studies, and encourages innovative designs such as platform, adaptive, and Bayesian trials. It funds trials testing therapeutic, behavioral, or prevention strategies that align with the NHLBI research mission, requiring a detailed scientific and operational plan.

Amount: Not stated
Type: Grant

Key facts

Key facts for Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
Amount	Not stated
Issuer	National Institutes of Health
Who can apply	Small businesses, companies, universities and 7 more
Sectors	HealthTech
Deadline	Closes 02 Nov 2028

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 23 hours ago

85 days agoagentImported from the official source

Opportunities with the same funding type or region
European Degree Exploratory Action		Closes 18 Feb 2027
Cooperative Agreement for affiliated Partner with Alaska Cooperative Ecosystem Studies Unit	up to $234,460	Closes 07 Dec 2026
Cooperative Agreement for affiliated Partner with Colorado Plateau Cooperative Ecosystem Studies Unit	up to $150,000	Closes 07 Dec 2026